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 Marine-derived fungi have proven to be rich sources of structurally 
novel and biologically active secondary metabolites, which are 
emerging as a significant new chemical resource for drug 
discovery.[1] During a search for natural products exhibiting 
pharmacologically interesting activities,[2] we screened extracts 
derived from marine organisms for cytotoxic activity. In this paper, 
we report the isolation, structure elucidation including absolute 
stereochemistry, and biological activities of four new doubly 
prenylated indole alkaloids, notoamides A-D (1-4), from a culture of 
marine-derived fungus, Aspergillus sp., isolated from the common 
mussel, Mytilus edulis. Biogenetically, notoamides are assumed to 
be related each other, and Williams et al. succeeded in the 
biomimetic synthesis of notoamides C (3) and D (4), which are 
reported in the successive paper.[3]  
The fungus, Aspergillus sp., was separated from the mussel, 
Mytilus edulis, collected off Noto Peninsula in the Japan Sea. The 
fungus was fermented on agar plates and extracted with EtOH. The 
extract was concentrated under reduced pressure, and the aqueous 
residue was partitioned against EtOAc, and then n-BuOH. The 
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EtOAc fraction was partitioned between hexane and 90% MeOH-
H2O, and cytotoxic activity was found in the aqueous MeOH and n-
BuOH fractions. The two active fractions were combined and 
subjected to ODS chromatography with aqueous MeOH. The 
fraction eluted with 80% MeOH-H2O was purified by ODS HPLC 
with 60% MeOH-H2O to afford four new alkaloids, notoamides A 
(1, 3.4 mg), B (2, 2.1 mg), C (3, 7.9 mg), and D (4, 8.9 mg), along 
with the known compounds, sclerotiamide[4] (5, 2.9 mg), stephacidin 
A[5] (6, 6.1 mg), and deoxybrevianamide E[6] (7, 0.57 mg) (Figure 1). 
Figure 1. Structures of compounds isolated from Aspergillus sp. 
 The FABMS of notoamide C (3) showed a quasi molecular 
ion peak at m/z 450 [M + H]+ and the molecular formula was 
determined as C26H31N3O4 on the basis of its HRFABMS, requiring 
thirteen degrees of unsaturation. The IR spectrum of 3 displayed 
amide absorption bands at 3500, 1700, and 1650 cm-1. The presence 
of the amides was also supported by the carbonyl signals at δ 164.8 
and 169.0 in the 13C NMR spectrum. The UV absorption at 247.5 
(log ε 4.3), 283.0 (3.9, sh), 294.0 (3.7, sh), and 319.5 nm (3.4, sh) 
was indicative of aromatic functionality with an extended 
conjugation. The 1H NMR spectrum in acetone-d6 revealed four 
singlet methyl signals, seven olefinic signals, and two exchangeable 
proton signals. The 13C NMR spectrum in acetone-d6 showed three 
carbonyl carbons, eight olefinic carbons, and four methyl signals. 
1H-1H COSY revealed the presence of a 1,2,3,4-tetrasubstituted 
benzene ring and a 1,2-disubstituted cis-double bond (Figure 2 (A)). 
Interpretation of HMBC correlations in acetone-d6, indicated the 
presence of a 5,6-disubstituted-2,2-dimethyl-2H-chromone moiety 
in which the benzene ring and double bond were incorporated. 
Connection of C-6 and C-27 via an oxygen atom was deduced by 
their chemical shifts. Analysis of 2D NMR spectra indicated the 
presence of a prenyl group (B), a partial structure (C), and a proline 
moiety (D) (Figure 2). Furthermore, HMBC correlations indicated 
that the NH was accommodated on a 2-oxindole ring of which the 
benzene ring was incorporated into the partial structure A and that 
the prenyl group (B) was attached to C-3. The HMBC correlations 
in DMSO-d6 indicated that the proline moiety formed a 
diketopiperazine ring (Figure 2). NOE experiment of 3 in acetone-d6 
revealed a correlation between H-11 and H-17, indicating that the 
notoamide A (1, R1=OH, R2=H)
notoamide B (2, R1=R2=H)
















































































diketopiperazine ring was of the cis-configuration. Acid hydrolysis 
of 3 followed by analysis using TLC on a chiral stationary phase 
(CHIRALPLATE®) showed the presence of L-proline in the 
hydrolysate. Therefore, the stereogenic centers of 3 were determined 
as being 11S,17S. Although the absolute configuration of the C-3 
stereogenic center was not determined by spectroscopic methods, 
the co-occurrence of notoamides A (1) and B (2) indicates the 3R 
configuration for 3 based on biogenetic considerations.  
Figure 2. Key HMBC correlations for 3.  
Notoamide D (4) has the same molecular formula as 3 and 
revealed that 1H and 13C NMR spectra were very similar to those of 
3. Analysis of 2D NMR data revealed that 4 contained a 
pyrroloindol ring, and the positions of a hydroxy and a prenyl 
groups were indicated by HMBC correlations (Figure 3 (A)). The 
relative stereochemistry of 4 was established by through its NOE 
spectrum (Figure 3 (B)). Analysis of acid hydrolysate of 4 by TLC 
on the chiral stationary phase showed that the proline moiety that 
constitutes 4 is L-proline. Thus, the absolute stereochemistry of 4 
was established as 2S,3R,11S,17S.  
Figure 3. Key HMBC (A) and NOE  (B) correlations for 4. 
The FABMS of notoamide B (2) showed a quasi molecular ion 
peak at m/z 448 [M + H]+ and the molecular formula was 
determined as C26H29N3O4 on the basis of its HRFABMS, requiring 
thirteen degrees of unsaturation. The 1H and 13C NMR spectra of 2 
in acetone-d6 were similar to those of 3 and 4, except for the absence 
of olefinic signals for the isoprenyl group present in 3 and 4. HMBC 
correlation indicated that 2 possessed a bicyclo[2.2.2]diazaoctane 
ring generated from a diketopiperazine ring and an isoprenyl group 
(Figure 4 (A)). NOE correlations observed in 2 indicated the relative 
stereochemistry as shown in Figure 4 (B). The CD spectrum of 2 
correlates to relevant regions of the CD spectrum of brevianamide 
B[7] and revealed that the absolute stereochemistry of 2 should be 
3R,11S,17S,21S (see Figure S5 in the Supporting Information). 
Williams et al. reported that the Cotton effect at 200-250 nm is due 
to an n-π* transition of the diketopiperazine amide bonds, which is 
diagnostic for the bicyclo[2.2.2]diaza octane diketopiperazine core. 
The absorption between 250~450 nm is diagnostic of the absolute 
stererochemistry at the spiro-oxindole stereogenic center and the 
sign of the Cotton effect for 2 correlated with that for (-)-
paraherquamide B.[8] The structure of 2  was accordingly revealed to 
be that of 10-desoxy-sclerotiamide: sclerotiamide (5) was reported 
to be a metabolite of Aspergillus sclerotiorum,[4] for which its 
absolute stereochemistry was proposed by analogy to that of 
paraherquamide (8).[8] A molecular formula of notoamide A (1) 
C26H29N3O5 was established by HRFABMS, an oxygen atom more 
than 2. The 1H and 13C NMR spectra of 1 were very similar to those 
of 2, except for the absence of the exchangeable broad NH (H-1) 
signal in 1. In addition, the differences of chemical shifts were 
observed for H-25 (δ 7.72 for 1 and δ 6.64 for 2) and C-2 (δ 178.8 
for 1 and δ 184.0 for 2). Taken together, we have concluded that the 
structure of 1 to be the 1-hydroxy derivative of 2. The CD spectrum 
of 1 reveals that the absolute stereochemistry is the same as that of 2 
(Figure S5). This is the first report of a naturally occurring 1-
hydroxy-2-oxindole alkaloid, although the synthesis of simple 1-
hydroxy-2-oxindoles has been reported.[9] 
Figure 4. Key HMBC (A) and NOE  (B) correlations for 2. 
Notoamides A-C (1-3) showed moderate cytotoxicity against 
HeLa and L1210 cells with IC50 values in the range of 22-52 µg/mL, 
but the IC50 value of notoamide D (4) was more than 100 µg/mL. 
Notoamide D (4) contains a pyrroloindol ring instead of a 
dihydroxypyrano-2-oxindole ring system common to notoamides A-
C (1-3), which is likely responsible for the marked differences in 
cytotoxicity. It is further significant that we have found that 3 
induced G2/M cell cycle arrest at a concentration of 6.3 µg/mL. 
Notoamides A-D (1-4) possess the pyranoindole ring system 
which is also common to stephacidin A (6), stephacidin B and 
several members of paraherquamide family. Notoamides A (1) and 
B (2) contain the bicyclo[2.2.2]diazaoctane ring system, which is 
proposed to be biosynthetically generated from an oxidized 
diketopiperazine ring and an isoprenyl group by the Diels-Alder 
reaction. [3] In 2005, the isolation of structurally related compounds, 
which were named norgeamides, was reported by the Hans-Knöll 
Institute. [10] The norgeamides and notoamides C (3) and D (4) 
appear to be closely related in their biogenesis and are plausible 
pathway metabolites leading to the more complex alkaloids 
stephacidin A (6) and notoamides A (1) and B (2). It is highly 
significant that the Aspergillus sp. that we have investigated here, 
exhibits one of the most extensive co-metabolite profiles within the 
numerous families of prenylated indole alkaloids extant and 
suggests a provocative biosynthetic sequence involving 
deoxybrevianamide E (7) to stephacidin A (6) to notoamide B (2) 
and then branching to notoamide A (1) or sclerotiamide (5). 
Recently, Williams et al. have succeeded in the biomimetic 
synthesis of notoamides B, C, and D (2-4), which have further 
corroborated the structural and stereochemical assignments made 





























































































































HMBC observed in acetone-d6
HMBC observed in DMSO-d6
 3 
for the norgeamides and notoamides including their biomimetic 
syntheses are reported in the accompanying paper.[3] 
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